Latest Breaking News On - சோதனை வலைப்பின்னல் - Page 7 : comparemela.com

Peraton Awarded $44M U S Army Hypersonic Testing & Evaluation Contract

Share this article Share this article HERNDON, Va., March 15, 2021 /PRNewswire/ Peraton has been awarded a U.S. Army contract for Hypersonic Test Engineering, Mission Planning and Systems (HyTEMPS), valued at up to $44 million over two years. This award builds upon Peraton s more than 10 years of experience supporting the U.S. Army Space and Missile Defense Command (USASMDC) Technical Center and its mission to develop hypersonic vehicle technologies and provide hypersonic weapon and vehicle flight testing capabilities. Under the contract, Peraton will be responsible for providing comprehensive mission support for interservice flight test missions, deploying whenever and wherever needed to ensure flight test events are successfully executed. To support these test events, Peraton will develop hardware and software solutions associated with the development, maintenance and sustainment, and operations of mission and test systems.

Roger masonUs army spaceMissile defense command technical centerDepartment of defenseTechnical centerLatest networkUs armyArmy portable range operationsMission planningHypersonic test engineeringMissile defense commandPortable range operationsரோஜர் கொத்தனார்எங்களுக்கு இராணுவம் இடம்ஏவுகணை பாதுகாப்பு கட்டளை தொழில்நுட்ப மையம்துறை ஆஃப் பாதுகாப்பு

INOVIO to Present at Upcoming Investor Conferences in March

INOVIO to Present at Upcoming Investor Conferences in March News provided by Share this article Share this article PLYMOUTH MEETING, Pa., March 4, 2021 /PRNewswire/ INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that Dr. J. Joseph Kim, President and CEO, along with other members of INOVIO management, will present at the following investor conferences in March: H.C. Wainwright Global Life Sciences Conference Date: Tuesday, March 9, 2021 Virtual 1x1 meetings only Date: Thursday, March 18, 2021 Time: 10:40 a.m. ET Presentation Format: Corporate Presentation

Ben matoneJeff richardsonKaneka eurogentecJ joseph kimWalter reed army institute of researchUs department of defenseNational cancer instituteNational institute of allergyPlumbline life sciencesMelinda gates foundationCoalition for epidemic preparedness innovationsHc wainwright global life sciences conferenceInternational vaccine instituteDefense consortiumParker institute for cancer immunotherapyNuclear defense

INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results

Share this article Share this article PLYMOUTH MEETING, Pa., March 1, 2021 /PRNewswire/ INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today reported financial results for the quarter ended December 31, 2020. INOVIO s management will host a live conference call and webcast at 4:30 p.m. Eastern Standard Time today to discuss financial results and provide a general business update, including: top-line efficacy data from REVEAL 1, a Phase 3 clinical trial of VGX-3100; a progress update for the company s INNOVATE Phase 2/3 COVID-19 vaccine clinical trial and its development strategy regarding the new COVID-19 vaccine addressing the current and future COVID variants of concern (VOC); and a general update on its DNA medicines platform. The live webcast and a replay may be accessed by visiting INOVIO s website at http://ir.inov

United statesHong kongUnited kingdomSouth africaMacau generalSouth africanBen matoneJeff richardsonKaneka eurogentecJ joseph kimWalter reed army institute of researchUs department of defenseNational cancer instituteNational institute of allergyUs department of defense doPlumbline life sciences

INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results

INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomSouth africaMacau generalSouth africanBen matoneJeff richardsonKaneka eurogentecJ joseph kimWalter reed army institute of researchUs department of defenseNational cancer instituteNational institute of allergyUs department of defense doPlumbline life sciences

CEPI partner INOVIO launches Lassa vaccine Phase I trial in West Africa

CEPI partner INOVIO launches Lassa vaccine Phase I trial in West Africa
ghanavisions.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ghanavisions.com Daily Mail and Mail on Sunday newspapers.

Ben matoneJeff richardsonKaneka eurogentecKwadwoa koramWalter reed army institute of researchUs department of defenseNational cancer instituteNoguchi memorial institute for medical researchNational institute of allergyPlumbline life sciencesMelinda gates foundationCoalition for epidemic preparedness innovationsInternational vaccine instituteDefense consortiumParker institute for cancer immunotherapyNuclear defense